top signin

Pin It

interior-banner-mask

.

Press 2018

Nov 08, 2018

Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors


Nov 08, 2018

Biostage Reports 2018 Third Quarter Financial Results


Nov 07, 2018

Ms. Ting Li Appointed to Biostage Board of Directors


Nov 06, 2018

Biostage awarded $1.1 million Phase II NIH SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for pediatric esophageal atresia


Nov 02, 2018

Biostage to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Operations


Aug 14, 2018

Biostage Reports 2018 Second Quarter Financial Results


Aug 09, 2018

Biostage to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Operations


May 31, 2018

Biostage Closes $3.6 Million Private Placement at a price of $3.60 per share


May 31, 2018

Hong Yu Appointed President of Biostage


May 25, 2018

Dr. Wei Zhang Elected to Biostage's Board of Directors


May 10, 2018

Biostage Reports 2018 First Quarter Financial Results


May 04, 2018

Biostage to Host Conference Call to Discuss First Quarter 2018 Financial Results and Operations


Apr 02, 2018

Biostage Reports 2017 Financial Results


Mar 29, 2018

Biostage Names Distinguished Children's Hospital Executive James Shmerling to its Board of Directors


Mar 29, 2018

Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients


Mar 13, 2018

Biostage Preclinical Study Results Published in New Report


Feb 20, 2018

Biostage Closes $1 Million Private Placement


Feb 20, 2018

Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD


Feb 12, 2018

Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD


Feb 12, 2018

Biostage, Inc. Names Jason Chen Chairman of its Board of Directors


Feb 06, 2018

Biostage to Host Conference Call to Provide Business Update


Jan 31, 2018

Biostage Appoints to its Scientific Advisory Board Christine Finck, MD, Executive Vice President, Surgeon-in-Chief at Connecticut Children's Medical Center


Jan 03, 2018

Biostage Closes $4.2 Million Private Placement